Top Markets
#1 Seeker Seeker +14.44%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.64%
#4 Solstice Solstice +6.07%
#5 aelf aelf +5.54%
#6 Official Trump Official Trump +5.49%
#7 Arowana Arowana +4.96%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +4.19%
#9 DexNet DexNet +3.67%
#10 The Black Bull The Black Bull +3.16%
Coin of the day
Seeker Seeker
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Rang în acțiuni #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Preț acțiune
$6.02
Ultima sincronizare: 2026-08-27
Capitalizare de piață
$1.93B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
112.72%
Țară
US
Tranzacționează Taysha Gene Therapies, Inc. (TSHA)

Categorie

Healthcare
Venituri pentru Taysha Gene Therapies, Inc. (TSHA)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Taysha Gene Therapies, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Taysha Gene Therapies, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH